ICNC2018 Abstracts & Symposia Proposals, ICNC 2014

Font Size: 
Biotin Responsive Basal Ganglia Disease : Unusual presentation with spinal cord involvement
Fahad A. Bashiri, Muddathir HA Hamad, Heba Y. El khashab, Saeed Hassan, Hamdy H. Hassan, Mustafa AM Salih

Last modified: 2014-04-03

Abstract


Background : Biotin responsive basal ganglia disease (BBGD) is a recessively inherited disorder manifested as subacute encephalopathy .It is  a rare disorder related to thiamine transporterII deficiency caused by mutation in SLC19A3 gene. Administration of high dose of Biotin and thiamine  resulted in significant .Here we report 2 cases of BBGD with different clinical presentation and one with cervical spinal cord  involvement.Case(1): a 13- year- old girl who was previously healthy presented at the age of 11 years with seizure, confusion and abnormal gait. (CSF) analysis was normal. MRI brain showed multiple lesions of high signal intensity involving the basal ganglia , cerebral and cerebellar white matter with alteration in signal intensity of cervical spine.She was diagnosed initially  as Acute Disseminating Encephalomyelitis ( ADEM), received IVIG and methylprednisolone without much improvement.DNA test identifies mutation in SLC19A3 gene. Administration of high dose Biotin and thiamine reverses the symptoms.Case(2) : a 2- year- old girl who presented with a 5 days history of unsteady gait,her brother died at age of 2 years with similar presentation.Her clinical examination showed dystonia. Laboratory investigations showed normal amino acids and urine organic acids profile.MRI brain demonstrated high signal intensity in subcortical white matter, red nuclei and basal ganglia bilaterally.DNA confirmed the diagnosis of BBGD.She responded dramatically to high dose of Biotin and thiamine . Conclusion: BBGD is a rare disorder that should be suspected in patients with subacute encephalopathy and  acute dystonias as early recognition and treatment prevents serious complications and eventually death.


Keywords


Metabolic disorders,BBGD,Biotin,Thiamine

References


1. Ozand PT, Gascon GG, Al Essa M, Joshi S, Al Jishi E, Bakheet S, Al Watban J, Al-Kawi
MZ, Dabbagh O: Biotin-responsive basal ganglia disease: a novel entity. Brain : a journal
of neurology 1998, 121(Pt 7):1267–1279.
2. Zeng WQ, Al-Yamani E, Acierno JS Jr, Slaugenhaupt S, Gillis T, MacDonald ME, Ozand
PT, Gusella JF: Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to
mutations in SLC19A3. American journal of human genetics 2005, 77:16–26.

3. El-Hajj TI, Karam PE, Mikati MA: Biotin-responsive basal ganglia disease: case report
and review of the literature. Neuropediatrics 2008, 39:268–271.
4. Bindu PS, Noone ML, Nalini A, Muthane UB, Kovoor JM: Biotin-responsive basal
ganglia disease: a treatable and reversible neurological disorder of childhood. J Child
Neurol 2009, 24:750–752.
5. Debs R, Depienne C, Rastetter A, Bellanger A, Degos B, Galanaud D, Keren B, Lyon-
Caen O, Brice A, Sedel F: Biotin-responsive basal ganglia disease in ethnic Europeans
with novel SLC19A3 mutations. Arch Neurol 2010, 67:126–130.
6. Yamada K, Miura K, Hara K, Suzuki M, Nakanishi K, Kumagai T, Ishihara N, Yamada Y,
Kuwano R, Tsuji S, Wakamatsu N: A wide spectrum of clinical and brain MRI findings in
patients with SLC19A3 mutations. BMC Med Genet 2010, 11:171.
7. Subramanian VS, Marchant JS, Said HM: Biotin-responsive basal ganglia disease-linked
mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for
hTHTR2. Am J Physiol Cell Physiol 2006, 291:C851–C859.


Conference registration is required in order to view papers.